Central nervous system stimulants and sport practice
نویسندگان
چکیده
منابع مشابه
Central Nervous System Stimulants
29 29 GENERIC NAME PAGE Amphetamine 350 Caffeine 351 Doxapram 349 Fenfluramine 351 Methamphetamine 350 Methylphenidate 350 Modafenil 351 GENERIC NAME PAGE Pemoline 350 Pentylenetetrazol 349 Sibutramine 351 Phentermine 351 Theobromine 351 Theophylline 351 Central nervous system (CNS) stimulation is the primary action of a diverse group of pharmacological agents and an adverse effect associated w...
متن کاملADENOSINE IN THE CENTRAL NERVOUS SYSTEM
Besides being a metabolite of nucleotides like ATP, adenosine is a mediator of neuronal function in the central nervous system. Its actions are mediated by at least three extracellular receptors. In this review different aspects of adenosine such as biosynthesis, release, inactivation and its receptors are discussed. It also covers pre- and postsynaptic effects as well as postreceptor mecha...
متن کاملP124: Listeriosis in Central Nervous System
Listeriosis is one of the CNS inflammatory diseases which is happened majority in the form of sporadic. Listeriosis is ingested with the food. Infection occurrence in an exposed person depends on the number of organisms ingested, the virulence of the organisms strain and the individual condition. It is known that Listeriosis has decisive importance as an infection which the cellular immunodefen...
متن کاملHYPERVITAMINOSIS A-INDUCED CENTRAL NERVOUS SYSTEM DEFECTS
In this investigation the effects of excess vitamin A administration during the early embryonic period were studied. Intramuscular injection of a single dose of 15000,20000 or 25000 IU/kg vitamin A to pregnant Balb/c strain mice on either day 7,8,9 or 10 of gestation (vaginal plug= day 0 of gestation) produced major malformations in the central nervous system (CNS) including exencephaly, h...
متن کاملCardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
OBJECTIVES Case reports have raised concerns about the risk of cardiac events associated with central nervous system stimulants for the treatment of attention-deficit/hyperactivity disorder. PATIENTS AND METHODS This was a retrospective cohort study that used 10 years (July 1994 to June 2004) of Florida Medicaid claims data cross-linked to Vital Statistics Death Registry data. The cohort was ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Sports Medicine
سال: 2006
ISSN: 0306-3674
DOI: 10.1136/bjsm.2006.027557